Annual rank82
Spain · Healthcare
Clinica Baviera
Ophthalmology-clinic network providing diagnosis, refractive and cataract procedures, specialist treatments and follow-up care for visual disorders.
FY2022–FY2025
FY2022–FY2025
FY2022–FY2025
current context only
Company profile
Eye-care pathways, country brands and a shared clinical platform
Clinica Baviera is a listed specialist eye-care group that operated 148 clinics across Spain, Germany, Austria, Italy and the United Kingdom at year-end 2025. Local brands—Baviera, CARE Vision and Optimax—combine laser refractive surgery, intraocular-lens procedures and broader ophthalmology. The network uses smaller consultation and follow-up sites alongside surgical clinics that share equipment, staff and management, supported by doctor training, common protocols and brand-level research.
Laser and lens procedures
One specialist network, several routes beyond glasses
Across the group, corneal-laser options include LASIK, LASEK and Trans-PRK, while lens routes include phakic ICLs and multifocal or monofocal replacements for higher prescriptions, presbyopia and cataracts. Assessment maps prescription, corneal anatomy and eye health before a clinician recommends a route; the offer is specialist surgery, not a single standard product.
- Compare LASIK and LASEK Optimax explains corneal treatment routes and assessment factors
- LASIK procedure CARE Vision's step-by-step outpatient laser pathway
- Trans-PRK A surface-laser route without creation of a corneal flap
- Lens implantation Phakic, multifocal and monofocal lens pathways
- ▶ VideoWatch: an optometrist explains ICL surgery Optimax's English overview of implantable-lens selection
Brands and geography
Three patient-facing names across five countries
At year-end 2025 the group reported 87 clinics in Spain, 32 across Germany and Austria, 19 in the United Kingdom and 10 in Italy. Baviera anchors Spain and Italy, CARE Vision serves German-speaking markets, and Optimax adds a British network. Country brands preserve local access and regulatory practice while belonging to one ophthalmology platform.
- CARE Vision within Clinica Baviera The brand relationship and shared ophthalmology scope
- CARE Vision branches German and Austrian consultation and treatment centres
- Optimax story The UK specialist founded in 1991 and acquired in 2024
- Optimax clinic network British locations from London to Scotland and Northern Ireland
- Baviera for international patients English-language coordination for care in Spain
Medical quality and learning
Protocols travel with research, training and named doctors
CARE Vision's R&D team reviews techniques for common protocols, supported by a central medical committee, a European Medical Advisory Board and cooperation with Hamburg-Eppendorf. The wider group uses Baviera Academy, mentoring and competency checks; Optimax publishes its surgeons and treatment technology so readers can inspect the clinical teams and equipment behind the brand.
- Research and medical governance Common protocols, advisory board and Hamburg-Eppendorf work
- CARE Vision doctors Named specialists and their clinical backgrounds
- Optimax technology Diagnostic, laser and lens-surgery equipment
- Optimax surgeons Named consultant ophthalmologists across the UK network
Network organisation
Assessment sites feed shared surgical capacity
The group distinguishes satellite clinics—patient acquisition, pre-operative assessment and follow-up—from surgical clinics with specialised equipment. Management units share people, assets and operational leadership across nearby sites; local contact centres use common scheduling and quality controls. Optimax's founder was also its first patient, an unusual origin for a treatment concept that later became part of a multi-country platform.
- Read the 2025 group report Clinic types, country footprint, training and strategy
- Audited-report library English and statutory group records by year
- A lens-surgery journey Assessment, procedure and follow-up in the UK brand
- ▶ VideoWatch: what happens at a consultation An Optimax ophthalmologist explains services and assessment
Official profile sources: Clínica Baviera Consolidated Management Report 2024 · Baviera — ¿Quiénes somos?
Current 2026 update
What has changed in 2026?
Q1 2026 · 27 May 2026
Q1 2026latest official update
4company-specific highlights
+18%2026 stock return · context only
Revenue
Q1 revenue increased 8.4% to EUR 87.0 million.
EBITDA
Q1 EBITDA increased 9.2% to EUR 26.4 million.
Profit
Q1 net result increased 14.2% to EUR 14.7 million.
Germany EBITDA
Germany EBITDA declined 6.4% to EUR 4.9 million, offsetting part of the group increase.
Official 2026 sources: Resultados Consolidados Primer Trimestre 2026 · 27 May 2026
Annual record
Ranking history
Future editions add rows; they do not rewrite the 2026 record.
| Edition | Measurement period | Rank | Revenue growth | Net-income growth | Stock return |
|---|---|---|---|---|---|
| 2026 | FY2022–FY2025 | 82 | +52% | +43% | +225% |